CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Standard Diagnostics Incorporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Standard Diagnostics Incorporation
156-68, Hagal-Dong
Giheung-Gu
Phone: (31) 899-9700p:31 899-9700 Yongin, Gyeonggi-Do, 446-930  South Korea Fax: (31) 899-9740f:31 899-9740

This is a Subsidiary, click here for the Parent Company

Business Summary
Standard Diagnostics, Inc is a Korea-based company engaged in the manufacturing and distribution of pharmaceutical products. The Company's products are categorized into five main lines: rapid test kits, enzyme-linked immunosorbent assay (ELISA) kits, urine test kits, bio sensor and medicine materials. Its rapid test kits are offered for a range of infectious diseases, including blood borne diseases, sexually transmitted diseases, dengue fever, febrile diseases and respiratory diseases, as well as other diseases such as fertility hormones and cancers. The ELISA kits consist of test kits for hepatitis B, hepatitis C, human immunodeficiency virus, malaria antigen, syphilis and others. The Company is part of Alere Inc., which is owned by Abbott Laboratories.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/200912/31/2009Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director Yeong SikCho 48
Vice President, Director Jin HyeonKim 47 1/1/2005
Vice President, Director Hyo GeunLee 46 3/22/2005 3/22/2005
4 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 7,635,068 (As of 12/31/2009)
Shareholders: 6,435
Stock Exchange: KDQ
Fax Number: (31) 899-9740


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023